Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Mometasone furoate - Generic Drug Details

« Back to Dashboard

What are the generic sources for mometasone furoate and what is the scope of mometasone furoate freedom to operate?

Mometasone furoate
is the generic ingredient in five branded drugs marketed by G And W Labs, Glenmark Generics, Fougera Pharms, Taro, Merck Sharp Dohme, Apotex Inc, Perrigo New York, Perrigo, Tolmar, and Amneal Pharms, and is included in twenty-five NDAs. There are six patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Mometasone furoate has thirty-four patent family members in twenty-six countries.

There are twenty-nine drug master file entries for mometasone furoate. Twenty-one suppliers are listed for this compound.

Summary for Generic Name: mometasone furoate

Tradenames:5
Patents:6
Applicants:10
NDAs:25
Drug Master File Entries: see list29
Suppliers / Packagers: see list21
Bulk Api Vendors: see list45
Clinical Trials: see list81
Patent Applications: see list4,691
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mometasone furoate at DailyMed

Pharmacology for Ingredient: mometasone furoate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics
MOMETASONE FUROATE
mometasone furoate
OINTMENT;TOPICAL078571-001May 28, 2008ABRXNoNo► Subscribe► Subscribe
Fougera Pharms
MOMETASONE FUROATE
mometasone furoate
CREAM;TOPICAL076171-001Apr 8, 2005ABRXNoNo► Subscribe► Subscribe
Merck Sharp Dohme
ASMANEX HFA
mometasone furoate
AEROSOL, METERED;INHALATION205641-002Apr 25, 2014RXYesYes6,068,832► SubscribeY ► Subscribe
Merck Sharp Dohme
ELOCON
mometasone furoate
CREAM;TOPICAL019625-002Apr 19, 2013ABRXYesYes► Subscribe► Subscribe
Taro
MOMETASONE FUROATE
mometasone furoate
OINTMENT;TOPICAL076624-001Dec 3, 2004DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot